Abstract
Epilepsy is a disorder of neural networks that is characterized by spontaneous recurrent seizures. The role of GABAB receptor-mediated mechanisms in the pathogenesis of seizures depends upon neural networks involved, which determine the seizure type. Generalized seizures involve diffuse, bi-hemispheric neuronal networks, while focal seizures involve regional brain networks. GABAB receptor agonists have been shown to diminish seizure activity in mouse models of both generalized convulsive and focal seizures. However, generalized non-convulsive seizures such as typical and atypical absence seizures (AASs) characteristically are exacerbated by GABAB receptor agonists and blocked by GABAB receptor antagonists. The reason for this dichotomy is the involvement of thalamic circuitry in both typical and atypical absence seizures. Thalamocortical circuitry underpins typical absence seizures (TASs) and hippocampal-thalamocortical circuitry is involved in AASs. In addition, high doses of GABAB receptor agonists active at the GABAB receptor/G-protein coupled inwardly rectifying potassium 2 (GIRK2) channel recently have been shown to induce the phenotype of a specific catastrophic epilepsy syndrome of childhood, infantile spasms, in mice. Therefore, GABAB receptor-mediated mechanisms can be pro- or anti-convulsant depending on the nature of the pathological neuronal networks involved. Although there are pre-clinical data in support of the efficacy of GABAB receptor agonists and antagonists in specific experimental models of seizures, these data have not been translated into the clinical arena because of the potential for downstream adverse effects. The therapeutic goal for the use of these compounds in epilepsy awaits a strategy that targets only those GABAB receptor for specific networks that are involved in a given pathological state.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexopoulos, H., Dagklis, I. E., Akrivou, S., Bostantjopoulou, S., & Dalakas, M. C. (2014). Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expression. Neurology: Neuroimmunology & Neuroinflammation, 1(4), e39.
Bare, M. A., Burnstine, T. H., Fisher, R. S., & Lesser, R. P. (1994). Electroencephalographic changes during simple partial seizures. Epilepsia, 35(4), 715–720.
Beenhakker, M. P., & Huguenard, J. R. (2009). Neurons that fire together also conspire together: Is normal sleep circuitry hijacked to generate epilepsy? Neuron, 62(5), 612–632.
Belichenko, N. P., Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Reeves, R. H., & Mobley, W. C. (2009). The “Down syndrome critical region” is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. Journal of Neuroscience, 29(18), 5938–5948.
Benke, D. (2013). GABAB receptor trafficking and interacting proteins: Targets for the development of highly specific therapeutic strategies to treat neurological disorders? Biochemical Pharmacology, 86(11), 1525–1530.
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., et al. (2010). Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology 2005-2009. Epilepsia, 51(4), 676–685.
Best, T. K., Siarey, R. J., & Galdzicki, Z. (2007). Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current. Journal of Neurophysiology, 97(1), 892–900.
Bilgic, B., Baykan, B., Gurses, C., & Gokyigit, A. (2001). Perioral myoclonia with absence seizures: A rare epileptic syndrome. Epileptic Disorders, 3(1), 23–27.
Billinton, A., Baird, V. H., Thom, M., Duncan, J. S., Upton, N., & Bowery, N. G. (2001). GABAB receptor autoradiography in hippocampal sclerosis associated with human temporal lobe epilepsy. British Journal of Pharmacology, 132(2), 475–480.
Blichowski, M., Shephard, A., Armstrong, J., Shen, L., Cortez, M. A., Eubanks, J. H., et al. (2015). The GIRK2 subunit is involved in ISs-like seizures induced by GABAB receptor agonists. Epilepsia, 56(7), 1081–1087.
Blumenfeld, H. (2005). Consciousness and epilepsy: Why are patients with absence seizures absent? Progress in Brain Research, 150, 271–286.
Bradley, W. G. (Ed.). (2012). Bradley’s neurology in clinical practice (6th ed.). Philadelphia, PA: Elsevier/Saunders. Chapter 67.
Callaghan, N., O’Hare, J., O’Driscoll, D., O’Neill, B., & Daly, M. (1982). Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Developmental Medicine and Child Neurology, 24(6), 830–836.
Carmant, L. (2002). Infantile spasms: West syndrome. Archives of Neurology, 59(2), 317–318.
Chan, K. F., Burnham, W. M., Jia, Z., Cortez, M. A., & Snead, O. C., 3rd. (2006). GABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizures. European Journal of Pharmacology, 541(1–2), 64–72.
Chen, L., Chan, Y. S., & Yung, W. H. (2004). GABA-B receptor activation in the rat globus pallidus potently suppresses pentylenetetrazol-induced tonic seizures. Journal of Biomedical Science, 11(4), 457–464.
Chiang, S., & Haneef, Z. (2014). Graph theory findings in the pathophysiology of temporal lobe epilepsy. Clinical Neurophysiology, 125(7), 1295–1305.
Connelly, W. M., Fyson, S., Errington, A. C., McCafferty, C. P., Cope, D. W., Di Giovanni, G., et al. (2013). GABAB receptors regulate extrasynaptic GABAA receptors. Journal of Neuroscience, 33(9), 3780–3785.
Cope, D. W., Di Giovanni, G., Fyson, S. J., Orban, G., Errington, A. C., Lorincz, M. L., et al. (2009). Enhanced tonic GABAA inhibition in typical absence epilepsy. Nature Medicine, 15(12), 1392–1398.
Cortez, M. A., McKerlie, C., & Snead, O. C., III. (2001). A model of atypical absence seizures: EEG, pharmacology, and developmental characterization. Neurology, 56(3), 341–349.
Cortez, M. A., Shen, L., Wu, Y., Aleem, I. S., Trepanier, C. H., Sadeghnia, H. R., et al. (2009). Infantile spasms and Down syndrome: A new animal model. Pediatric Research, 65(5), 499–503.
Crunelli, V., & Leresche, N. (2002). Childhood absence epilepsy: Genes, channels, neurons, and networks. Nature Reviews Neuroscience, 3(5), 371–382.
Davisson, M. T., Schmidt, C., & Akeson, E. C. (1990). Segmental trisomy of murine chromosome 16: A new system for studying Down syndrome. In D. Patteron & C. J. Epstein (Eds.), Molecular genetics of chromosome 21 and Down syndrome (pp. 263–280). New York: Wiley-Liss.
Dhir, A. (2012). Pentylenetetrazol (PTZ) kindling model of epilepsy. Current Protocols in Neuroscience, 9(37), 1–9.
Dugladze, T., Maziashvili, N., Börgers, C., Gurgenidze, S., Haussler, U., Winkelmann, A., et al. (2013). GABA(B) autoreceptor-mediated cell type-specific reduction of inhibition in epileptic mice. Proceedings of the National Academy of Sciences of the United States of America, 110(37), 15073–15078.
Engel, J. (2013). Chapter 9: Periictal phenomena. In Seizures and epilepsy (pp. 320–341). New York, NY: Oxford University Press.
French, J. (2003). A gene polymorphism associated with temporal lobe epilepsy? Epilepsy Currents, 3(4), 123–124.
Glauser, T. A., Cnaan, A., Shinnar, S., Hirtz, D. G., Dlugos, D., Masur, D., et al. (2013). Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months. Epilepsia, 54(1), 141–155.
Go, C. Y., Mackay, M. T., Weiss, S. K., Stephens, D., Adams-Webber, T., Ashwal, S., et al. (2012). Evidence based guideline update: Medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology, 78(24), 1974–1980.
Hamer, H. M., Lüders, H. O., Knake, S., Fritsch, B., Oertel, W. H., & Rosenow, F. (2003). Electrophysiology of focal clonic seizures in humans: A study using subdural and depth electrodes. Brain, 126(Pt 3), 547–555.
Han, H. A., Cortez, M. A., & Snead, O. C., III. (2012). GABAB receptor and absence epilepsy. In J. L. Noebels, M. Avoli, M. A. Rogawski, R. W. Olsen, & A. V. Delgado-Escueta (Eds.), Jasper’s basic mechanisms of the epilepsies [Internet] (4th ed., pp. 242–256). Bethesda, MD: National Center for Biotechnology Information (US).
Höftberger, R., Titulaer, M. J., Sabater, L., Dome, B., Rozsas, A., Hegedus, B., et al. (2013). Encephalitis and GABAB receptor antibodies: Novel findings in a new case series of 20 patients. Neurology, 81(17), 1500–1506.
Huguenard, J. R., & Prince, D. A. (1994). Clonazepam suppresses GABAB-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. Journal of Neurophysiology, 71(6), 2576–2581.
Huo, J. Z., Cortez, M. A., & Snead, O. C. (2009). GABA receptor proteins within lipid rafts in the AY-9944 model of atypical absence seizures. Epilepsia, 50(4), 776–788.
Intusoma, U., Abbott, D. F., Masterton, R. A., Stagnitti, M. R., Newton, M. R., Jackson, G. D., et al. (2013). Tonic seizures of Lennox-Gastaut syndrome: Periictal single-photon emission computed tomography suggests a corticopontine network. Epilepsia, 54(12), 2151–2157.
Jagirdar, R., Drexel, M., Kirchmair, E., Tasan, R. O., & Sperk, G. (2015). Rapid changes in expression of class I and IV histone deacetylases during epileptogenesis in mouse models of temporal lobe epilepsy. Experimental Neurology, 273, 92–104.
Karameh, F. N., & Massaquoi, S. G. (2009). Intracortical augmenting responses in networks of reduced compartmental models of tufted layer 5 cells. Journal of Neurophysiology, 101(1), 207–233.
Karlsson, G., Klebs, K., Hafner, T., Schmutz, M., & Olpe, H. R. (1992). Blockade of GABAB receptors accelerates amygdala kindling development. Experientia, 48(8), 748–751.
Kaufman, D. M. (2007). Epilepsy. In D. M. Kaufman (Ed.), Clinical neurology for psychiatrists (pp. 203–240). Philadelphia, PA: Saunders Elsevier.
Kelly, K. M., Valeriano, J. P., & Solot, J. A. (1999). Chapter 12: Seizures. In S. M. Shah & K. M. Kelly (Eds.), Emergency neurology: Principles and practice (pp. 154–172). Cambridge, UK: Cambridge University Press.
Kenyon, K., Mintzer, S., & Nei, M. (2014). Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy. Seizure, 23(3), 234–236.
Khosravani, H., & Zamponi, G. W. (2006). Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiological Reviews, 86(3), 941–966.
Klioueva, I. A., van Luijtelaar, E. L., Chepurnova, N. E., & Chepurnov, S. A. (2001). PTZ-induced seizures in rats: Effects of age and strain. Physiology & Behavior, 72(3), 421–426.
Kruer, M. C., Hoeftberger, R., Lim, K. Y., Coryell, J. C., Svoboda, M. D., Woltjer, R. L., et al. (2014). Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: The first pediatric case of GABA(B) receptor autoimmunity. JAMA Neurology, 71(5), 620–623.
Lang, M., Moradi-Chameh, H., Zahid, T., Gane, J., Wu, C., et al. (2014). Regulating hippocampal hyperexcitability through GABAB receptors. Physiological Reports, 2(4), e00278.
Lason, W., Chlebicka, M., & Rejdak, K. (2013). Research advances in basic mechanisms of seizures and antiepileptic drug action. Pharmacological Reports, 65(4), 787–801.
Lee, Y. J., Kang, H. C., Seo, J. H., Lee, J. S., & Kim, H. D. (2010). Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy. Brain and Development, 32(3), 208–212.
Lévesque, M., & Avoli, M. (2013). The kainic acid model of temporal lobe epilepsy. Neuroscience & Biobehavioral Reviews, 37, 2887–2899.
Libenson, M. H. (2010). Chapter 10: The EEG in epilepsy. In M. H. Libenson (Ed.), Practical approach to electroencephalography. Philadelphia, PA: Saunders Elsevier.
Liu, Z. L., Ma, H., Xu, R. X., Dai, Y. W., Zhang, H. T., Yao, X. Q., et al. (2012). Potassium channels underlie postsynaptic but not presynaptic GABAB receptor-mediated inhibition on ventrolateral periaqueductal gray neurons. Brain Research Bulletin, 88(5), 529–533.
Lott, I. T. (2012). Neurological phenotypes for Down syndrome across the life span. Progress in Brain Research, 197, 101–121.
Mattson, R. H., Cramer, J. A., & Collins, J. F. (1992). A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. New England Journal of Medicine, 327(11), 765–771.
Modebadze, T., Morgan, N. H., Pérès, I. A., Hadid, R. D., Amada, N., Hill, C., et al. (2016). A low mortality, high morbidity reduced intensity status epilepticus (RISE) model of epilepsy and epileptogenesis in the rat. PLoS One, 11(2), e0147265.
Motohashi, N., Ikawa, K., & Kariya, T. (1989). GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders? European Journal of Pharmacology, 166(1), 95–99.
Nishida, N., Huang, Z. L., Mikuni, N., Miura, Y., Urade, Y., & Hashimoto, N. (2007). Deep brain stimulation of the posterior hypothalamus activates the histaminergic system to exert antiepileptic effect in rat pentylenetetrazol model. Experimental Neurology, 205(1), 132–144.
Nolan, M., Bergazar, M., Chu, B., Cortez, M. A., & Snead, O. C., 3rd. (2005). Clinical and neurophysiologic spectrum associated with atypical absence seizures in children with intractable epilepsy. Journal of Child Neurology, 20(5), 404–410.
Onat, F. Y., van Luijtelaar, G., Nehllig, A., & Snead, O. C. (2013). The involvement of limbic structures in typical and atypical absence epilepsy. Epilepsy Research, 103(2–3), 111–123.
Pacey, L. K., Heximer, S. P., & Hampson, D. R. (2009). Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures. Molecular Pharmacology, 76(1), 18–24.
Panayiotopoulos, C. P. (2005). Chapter 10: Idiopathic generalized epilepsies. In C. P. Panayiotopoulos (Ed.), The epilepsies: Seizures, syndromes and management. Bladon Medical: Oxfordshire, UK.
Perez-Reyes, E. (2003). Molecular physiology of low voltage activated T-type calcium channels. Physiological Reviews, 83(1), 117–161.
Perez-Velazquez, J. L., Huo, J. Z., Garcia Dominguez, L. G., Leshchenko, Y., & Snead, O. C., III. (2007). Typical versus atypical absence seizures: Network mechanisms of the spread of paroxysms. Epilepsia, 48(8), 1585–1593.
Pitkanen, A., & Lukasiuk, K. (2011). Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurology, 10(2), 173–186.
Raimondo, J. V., Burman, R. J., Katz, A. A., & Akerman, C. J. (2015). Ion dynamics during seizures. Frontiers in Cellular Neuroscience, 9, 419.
Richardson, M. P. (2012). Large scale models of epilepsy: Dynamics meets connectomics. Journal of Neurology, Neurosurgery & Psychiatry, 83(12), 1238–1248.
Sander, T., Peters, C., Kämmer, G., Samochowiec, J., Zirra, M., Mischke, D., et al. (1999). Association analysis of exonic variants of the gene encoding the GABAB receptor and idiopathic generalized epilepsy. American Journal of Medical Genetics, 88(4), 305–310.
Schuler, V., Lüscher, C., Blanchet, C., Klix, N., Sansig, G., Klebs, K., et al. (2001). Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron, 31(1), 47–58.
Seeck, M., Schomer, D. L., & Niedermeyer, E. (2005). Chapter 33: Intracranial monitoring, depth, subdural, and foramen ovale electrodes. In E. Niedermeyer & F. L. De Silva (Eds.), Electroencephalography: Basic principles, clinical applications and related fields (5th ed., pp. 677–714). Baltimore, MD: Lippincott, Williams and Wilkins.
Smith, S. J. (2005). EEG in the diagnosis, classification, and management of patients with epilepsy. Journal of Neurology, Neurosurgery & Psychiatry, 76(Suppl 2), ii2–ii7.
Snead, O. C. (2002). γ-Hydroxybutyrate and absence seizure activity. In G. Tunnicliff & C. D. Cash (Eds.), Gamma-hydroxybutyrate: Molecular, functional, and clinical aspects (pp. 132–149). New York: Taylor Francis.
Snead, O. C., Banerjee, P. K., Burnham, M., & Hampson, D. (2000). Modulation of absence seizures by the GABA(A) receptor: A critical role for metabotropic glutamate receptor (mGLUR4). Journal of Neuroscience, 20(16), 6218–6224.
Snead, O. C., Cortez, M. A., Francis, J., & Eubanks, J. (2000). GABAB receptor gene expression is altered in an animal model of atypical absence epilepsy. Epilepsia, 41(Suppl 7), 23.
Snead, O. C., Depaulis, A., Vergnes, M., & Marescaux, C. (1999). Absence epilepsy: Advances in experimental animal models. Advances in Neurology, 79, 253–278.
Snead, O. C., 3rd, & Hosey, L. C. (1985). Exacerbation of seizures in children by carbamazepine. New England Journal of Medicine, 313(15), 916–921.
Spencer, S. S. (2002). Neural networks in human epilepsy: Evidence of and implications for treatment. Epilepsia, 43(3), 219–227.
Squires, R. F., Saederup, E., Crawley, J. N., Skolnick, P., & Paul, S. M. (1984). Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sciences, 35(14), 1439–1444.
Steriade, M. (2005). Sleep, epilepsy, and thalamic reticular inhibitory neurons. Trends in Neurosciences, 28(6), 317–324.
Stewart, L. S., Wu, Y., Eubanks, J. H., Han, H., Leschenko, Y., Perez Velazquez, J. L., et al. (2009). Severity of atypical absence phenotype in GABAB transgenic mice is subunit specific. Epilepsy & Behavior, 14(4), 577–581.
Velísková, J., Velísek, L., & Moshé, S. L. (1996). Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats. Epilepsia, 37(8), 718–722.
Vergnes, M., Boehrer, A., Simler, S., Bernasconi, R., & Morescaux, C. (1997). Opposite effects of GABAB receptor antagonists on absences and convulsive seizures. European Journal of Pharmacology, 332(3), 245–255.
Verrotti, A., Cusmai, R., Nicita, F., Pizzolorusso, A., Elia, M., Zamponi, N., et al. (2013). Electroclinical features and long term outcome of cryptogenic epilepsy children with Down syndrome. Journal of Pediatrics, 163(6), 1754–1758.
Wang, X., Stewart, L., Cortez, M. A., Wu, Y., Velazquez, J. L., Liu, C. C., et al. (2009). The circuitry of atypical absence seizures in GABA(B)R1a transgenic mice. Pharmacology, Biochemistry and Behavior, 94(1), 124–130.
Widjaja, E., Go, C., McCoy, B., & Snead, O. C., 3rd. (2015). Neurodevelopmental outcome of infantile spasms: A systematic review and meta-analysis. Epilepsy Research, 109, 155–162.
Wu, Y., Chan, K. F., Eubanks, J. H., Guin Ting Wong, C., Cortez, M. A., Shen, L., et al. (2007). Transgenic mice over-expressing GABA(B)R1a receptors acquire an atypical absence epilepsy-like phenotype. Neurobiology of Disease, 26(2), 439–451.
Wurpel, J. N., Sperber, E. F., & Moshé, S. L. (1990). Baclofen inhibits amygdala kindling in immature rats. Epilepsy Research, 5(1), 1–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Joshi, K., Cortez, M.A., Snead, O.C. (2016). Targeting the GABAB Receptor for the Treatment of Epilepsy. In: Colombo, G. (eds) GABAB Receptor. The Receptors, vol 29. Humana Press, Cham. https://doi.org/10.1007/978-3-319-46044-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-46044-4_10
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-46042-0
Online ISBN: 978-3-319-46044-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)